July 19, 2018 by Dennis Thompson, HealthDay Reporter (HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows. Endari, a medicine-grade version of the dietary supplement L-glutamine, reduced sickle cell patients’ number of acute pain crises by 25 percent compared with a placebo, the researchers found....
Tag: <span>Sickle Cell Drug</span>
Post
FDA Approves First Sickle Cell Drug in 20 Years
A scanning electron micrograph (SEM) of a sickle cell red blood cell found in a blood specimen of an 18 year old female patient. The FDA approved a new medicine Friday to reduce the complications associated with sickle cell disease, a rare blood disorder. The drug, Endari, is made by privately held Emmaus Medical...